Raising the Index of Suspicion in Primary Care: The Role of the Nurse Practitioner in Recognizing and Managing Diabetic Kidney Disease Evaluation (ID: i816b-1) Survey

1.How many years have you been in practice?(Required.)

>21

11-20

1-10

<1

2.How many patients with DKD do you manage per week?  (Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

3.Please select the option that best describes your practice setting:(Required.)

Hospital Network

Institutional Setting (skilled-nursing facilities, correctional facilities, mental hospitals and psychiatric units)

Retail Pharmacy

Urgent Care

Private Practice

Group Practice

Other (please specify)

4.After participating in this activity, how confident are you in the management of patients with DKD in your practice? (Required.)

5.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

If not committed or do not plan to make changes, please indicate reason

6.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

7.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Increase frequency of screening for DKD in patients with diabetes

Monitor serum creatinine and potassium levels in patients with diabetes

More vigilantly monitor CV risk in patients with diabetes and kidney disease

Consider clinical strategies that reduce the effects of aldosterone on inflammation and fibrosis

Incorporate therapies that improve DKD outcomes in the management of patients with diabetes

8.What barriers do you see to making changes in your practice? Please select all that apply.(Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

12.Overall, was this activity fair and balanced (Required.)

Yes

No

If No, please explain:

13.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

14.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or a related disease state:

15.If you indicated that you perceived commercial bias or influence, please describe: